サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1118560

世界の細胞生存率アッセイ市場：考察と予測 (2028年まで)

Global Cell Viability Assays Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の細胞生存率アッセイ市場：考察と予測 (2028年まで)
出版日: 2022年08月25日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、細胞生存率アッセイ (Cell Viability Assays) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の細胞生存率アッセイの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Human Cells
    • Microbial Cells
    • Animal Cells
  • 市場：アプリケーション別
    • 世界の細胞生存率アッセイの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Hospital and Diagnostic Laboratories
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の細胞生存率アッセイの市場展望 (2017-2028)
  • 細胞生存率アッセイの市場成長トレンド：地域別
    • 細胞生存率アッセイ 市場規模：地域別: 2017 VS 2021 VS 2028
    • 細胞生存率アッセイの市場規模実績：地域別 (2017-2022)
    • 細胞生存率アッセイの市場規模予測：地域別 (2023-2028)
  • 細胞生存率アッセイ 市場動向
    • 細胞生存率アッセイ 業界動向
    • 細胞生存率アッセイ 市場の促進要因
    • 細胞生存率アッセイ 市場の課題
    • 細胞生存率アッセイ 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の細胞生存率アッセイの上位企業：収益別
    • 世界の細胞生存率アッセイの上位企業：収益別 (2017-2022)
    • 世界の細胞生存率アッセイの収益シェア：企業別 (2017-2022)
  • 世界の細胞生存率アッセイの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：細胞生存率アッセイの収益
  • 世界の細胞生存率アッセイ 市場集中度
    • 世界の細胞生存率アッセイ 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 細胞生存率アッセイの収益 2021
  • 細胞生存率アッセイの主要企業の本社および事業エリア
  • 主要企業 細胞生存率アッセイの製品ソリューションおよびサービス
  • 市場参入時期： 細胞生存率アッセイ 市場
  • M&A, 拡張計画

第4章 細胞生存率アッセイ 内訳データ：タイプ別

  • 世界の細胞生存率アッセイの市場規模実績：タイプ別 (2017-2022)
  • 世界の細胞生存率アッセイの市場規模予測：タイプ別 (2023-2028)

第5章 細胞生存率アッセイ 内訳データ：アプリケーション別

  • 世界の細胞生存率アッセイの市場規模実績：アプリケーション別 (2017-2022)
  • 世界の細胞生存率アッセイの市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の細胞生存率アッセイ 市場規模 (2017-2028)
  • 北米の細胞生存率アッセイ 市場規模：タイプ別
    • 北米の細胞生存率アッセイ 市場規模：タイプ別 (2017-2022)
    • 北米の細胞生存率アッセイ 市場規模：タイプ別 (2023-2028)
    • 北米の細胞生存率アッセイの市場シェア：タイプ別 (2017-2028)
  • 北米の細胞生存率アッセイ 市場規模：アプリケーション別
    • 北米の細胞生存率アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 北米の細胞生存率アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 北米の細胞生存率アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 北米の細胞生存率アッセイ 市場規模：国別
    • 北米の細胞生存率アッセイ 市場規模：国別 (2017-2022)
    • 北米の細胞生存率アッセイ 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の細胞生存率アッセイ 市場規模 (2017-2028)
  • 欧州の細胞生存率アッセイ 市場規模：タイプ別
    • 欧州の細胞生存率アッセイ 市場規模：タイプ別 (2017-2022)
    • 欧州の細胞生存率アッセイ 市場規模：タイプ別 (2023-2028)
    • 欧州の細胞生存率アッセイの市場シェア：タイプ別 (2017-2028)
  • 欧州の細胞生存率アッセイ 市場規模：アプリケーション別
    • 欧州の細胞生存率アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 欧州の細胞生存率アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 欧州の細胞生存率アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 欧州の細胞生存率アッセイ 市場規模：国別
    • 欧州の細胞生存率アッセイ 市場規模：国別 (2017-2022)
    • 欧州の細胞生存率アッセイ 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 細胞生存率アッセイ 市場規模 (2017-2028)
  • アジア太平洋地域 細胞生存率アッセイ 市場規模：タイプ別
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 細胞生存率アッセイの市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 細胞生存率アッセイ 市場規模：アプリケーション別
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 細胞生存率アッセイの市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 細胞生存率アッセイ 市場規模：地域別
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 細胞生存率アッセイ 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの細胞生存率アッセイ 市場規模 (2017-2028)
  • ラテンアメリカの細胞生存率アッセイ 市場規模：タイプ別
    • ラテンアメリカの細胞生存率アッセイ 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの細胞生存率アッセイ 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの細胞生存率アッセイの市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの細胞生存率アッセイ 市場規模：アプリケーション別
    • ラテンアメリカの細胞生存率アッセイ 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの細胞生存率アッセイ 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの細胞生存率アッセイの市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの細胞生存率アッセイ 市場規模：国別
    • ラテンアメリカの細胞生存率アッセイ 市場規模：国別 (2017-2022)
    • ラテンアメリカの細胞生存率アッセイ 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの細胞生存率アッセイ 市場規模 (2017-2028)
  • 中東・アフリカの細胞生存率アッセイ 市場規模：タイプ別
    • 中東・アフリカの細胞生存率アッセイ 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの細胞生存率アッセイ 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの細胞生存率アッセイの市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの細胞生存率アッセイ 市場規模：アプリケーション別
    • 中東・アフリカの細胞生存率アッセイ 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの細胞生存率アッセイ 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの細胞生存率アッセイの市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの細胞生存率アッセイ 市場規模：国別
    • 中東・アフリカの細胞生存率アッセイ 市場規模：国別 (2017-2022)
    • 中東・アフリカの細胞生存率アッセイ 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad
  • GE
  • Danaher
  • BD
  • PerkinElmer
  • Promega
  • Biotium
  • Abcam
  • Creative Bioarray
  • Biotek Instruments

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Human Cells
  • Table 3. Key Players of Microbial Cells
  • Table 4. Key Players of Animal Cells
  • Table 5. Global Cell Viability Assays Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Cell Viability Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Cell Viability Assays Market Share by Region (2017-2022)
  • Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Cell Viability Assays Market Share by Region (2023-2028)
  • Table 11. Cell Viability Assays Market Trends
  • Table 12. Cell Viability Assays Market Drivers
  • Table 13. Cell Viability Assays Market Challenges
  • Table 14. Cell Viability Assays Market Restraints
  • Table 15. Global Cell Viability Assays Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Cell Viability Assays Revenue Share by Players (2017-2022)
  • Table 17. Global Top Cell Viability Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
  • Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Cell Viability Assays Product Solution and Service
  • Table 22. Date of Enter into Cell Viability Assays Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Cell Viability Assays Revenue Market Share by Type (2017-2022)
  • Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Cell Viability Assays Revenue Market Share by Type (2023-2028)
  • Table 28. Global Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Cell Viability Assays Revenue Share by Application (2017-2022)
  • Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Cell Viability Assays Revenue Share by Application (2023-2028)
  • Table 32. North America Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Cell Viability Assays Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Thermo Fisher Scientific Company Details
  • Table 63. Thermo Fisher Scientific Business Overview
  • Table 64. Thermo Fisher Scientific Cell Viability Assays Product
  • Table 65. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 66. Thermo Fisher Scientific Recent Developments
  • Table 67. Merck Company Details
  • Table 68. Merck Business Overview
  • Table 69. Merck Cell Viability Assays Product
  • Table 70. Merck Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 71. Merck Recent Developments
  • Table 72. Bio-Rad Company Details
  • Table 73. Bio-Rad Business Overview
  • Table 74. Bio-Rad Cell Viability Assays Product
  • Table 75. Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 76. Bio-Rad Recent Developments
  • Table 77. GE Company Details
  • Table 78. GE Business Overview
  • Table 79. GE Cell Viability Assays Product
  • Table 80. GE Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 81. GE Recent Developments
  • Table 82. Danaher Company Details
  • Table 83. Danaher Business Overview
  • Table 84. Danaher Cell Viability Assays Product
  • Table 85. Danaher Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 86. Danaher Recent Developments
  • Table 87. BD Company Details
  • Table 88. BD Business Overview
  • Table 89. BD Cell Viability Assays Product
  • Table 90. BD Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 91. BD Recent Developments
  • Table 92. PerkinElmer Company Details
  • Table 93. PerkinElmer Business Overview
  • Table 94. PerkinElmer Cell Viability Assays Product
  • Table 95. PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 96. PerkinElmer Recent Developments
  • Table 97. Promega Company Details
  • Table 98. Promega Business Overview
  • Table 99. Promega Cell Viability Assays Product
  • Table 100. Promega Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 101. Promega Recent Developments
  • Table 102. Biotium Company Details
  • Table 103. Biotium Business Overview
  • Table 104. Biotium Cell Viability Assays Product
  • Table 105. Biotium Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 106. Biotium Recent Developments
  • Table 107. Abcam Company Details
  • Table 108. Abcam Business Overview
  • Table 109. Abcam Cell Viability Assays Product
  • Table 110. Abcam Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 111. Abcam Recent Developments
  • Table 112. Creative Bioarray Company Details
  • Table 113. Creative Bioarray Business Overview
  • Table 114. Creative Bioarray Cell Viability Assays Product
  • Table 115. Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 116. Creative Bioarray Recent Developments
  • Table 117. Biotek Instruments Company Details
  • Table 118. Biotek Instruments Business Overview
  • Table 119. Biotek Instruments Cell Viability Assays Product
  • Table 120. Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
  • Table 121. Biotek Instruments Recent Developments
  • Table 122. Research Programs/Design for This Report
  • Table 123. Key Data Information from Secondary Sources
  • Table 124. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cell Viability Assays Market Share by Type: 2021 VS 2028
  • Figure 2. Human Cells Features
  • Figure 3. Microbial Cells Features
  • Figure 4. Animal Cells Features
  • Figure 5. Global Cell Viability Assays Market Share by Application: 2021 VS 2028
  • Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
  • Figure 7. Academic and Research Institutes Case Studies
  • Figure 8. Hospital and Diagnostic Laboratories Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Cell Viability Assays Report Years Considered
  • Figure 11. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Cell Viability Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Cell Viability Assays Market Share by Region: 2021 VS 2028
  • Figure 14. Global Cell Viability Assays Market Share by Players in 2021
  • Figure 15. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2021
  • Figure 17. North America Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Cell Viability Assays Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Cell Viability Assays Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Cell Viability Assays Market Size Share by Country (2017-2028)
  • Figure 21. United States Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Cell Viability Assays Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Cell Viability Assays Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Cell Viability Assays Market Size Share by Country (2017-2028)
  • Figure 27. Germany Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Cell Viability Assays Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Cell Viability Assays Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Cell Viability Assays Market Size Share by Region (2017-2028)
  • Figure 37. China Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 43. Latin America Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Cell Viability Assays Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Cell Viability Assays Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Cell Viability Assays Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Cell Viability Assays Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Cell Viability Assays Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Cell Viability Assays Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 57. Merck Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 58. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 59. GE Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 60. Danaher Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 61. BD Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 62. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 63. Promega Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 64. Biotium Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 65. Abcam Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 66. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 67. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
目次

This research report focuses on the Cell Viability Assays Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Human Cells
    • 1.2.3 Microbial Cells
    • 1.2.4 Animal Cells
  • 1.3 Market by Application
    • 1.3.1 Global Cell Viability Assays Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical and Biotechnology Companies
    • 1.3.3 Academic and Research Institutes
    • 1.3.4 Hospital and Diagnostic Laboratories
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cell Viability Assays Market Perspective (2017-2028)
  • 2.2 Cell Viability Assays Growth Trends by Region
    • 2.2.1 Cell Viability Assays Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Cell Viability Assays Historic Market Size by Region (2017-2022)
    • 2.2.3 Cell Viability Assays Forecasted Market Size by Region (2023-2028)
  • 2.3 Cell Viability Assays Market Dynamics
    • 2.3.1 Cell Viability Assays Industry Trends
    • 2.3.2 Cell Viability Assays Market Drivers
    • 2.3.3 Cell Viability Assays Market Challenges
    • 2.3.4 Cell Viability Assays Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cell Viability Assays Players by Revenue
    • 3.1.1 Global Top Cell Viability Assays Players by Revenue (2017-2022)
    • 3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2017-2022)
  • 3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Cell Viability Assays Revenue
  • 3.4 Global Cell Viability Assays Market Concentration Ratio
    • 3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2021
  • 3.5 Cell Viability Assays Key Players Head office and Area Served
  • 3.6 Key Players Cell Viability Assays Product Solution and Service
  • 3.7 Date of Enter into Cell Viability Assays Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Viability Assays Breakdown Data by Type

  • 4.1 Global Cell Viability Assays Historic Market Size by Type (2017-2022)
  • 4.2 Global Cell Viability Assays Forecasted Market Size by Type (2023-2028)

5 Cell Viability Assays Breakdown Data by Application

  • 5.1 Global Cell Viability Assays Historic Market Size by Application (2017-2022)
  • 5.2 Global Cell Viability Assays Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Cell Viability Assays Market Size (2017-2028)
  • 6.2 North America Cell Viability Assays Market Size by Type
    • 6.2.1 North America Cell Viability Assays Market Size by Type (2017-2022)
    • 6.2.2 North America Cell Viability Assays Market Size by Type (2023-2028)
    • 6.2.3 North America Cell Viability Assays Market Share by Type (2017-2028)
  • 6.3 North America Cell Viability Assays Market Size by Application
    • 6.3.1 North America Cell Viability Assays Market Size by Application (2017-2022)
    • 6.3.2 North America Cell Viability Assays Market Size by Application (2023-2028)
    • 6.3.3 North America Cell Viability Assays Market Share by Application (2017-2028)
  • 6.4 North America Cell Viability Assays Market Size by Country
    • 6.4.1 North America Cell Viability Assays Market Size by Country (2017-2022)
    • 6.4.2 North America Cell Viability Assays Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Cell Viability Assays Market Size (2017-2028)
  • 7.2 Europe Cell Viability Assays Market Size by Type
    • 7.2.1 Europe Cell Viability Assays Market Size by Type (2017-2022)
    • 7.2.2 Europe Cell Viability Assays Market Size by Type (2023-2028)
    • 7.2.3 Europe Cell Viability Assays Market Share by Type (2017-2028)
  • 7.3 Europe Cell Viability Assays Market Size by Application
    • 7.3.1 Europe Cell Viability Assays Market Size by Application (2017-2022)
    • 7.3.2 Europe Cell Viability Assays Market Size by Application (2023-2028)
    • 7.3.3 Europe Cell Viability Assays Market Share by Application (2017-2028)
  • 7.4 Europe Cell Viability Assays Market Size by Country
    • 7.4.1 Europe Cell Viability Assays Market Size by Country (2017-2022)
    • 7.4.2 Europe Cell Viability Assays Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell Viability Assays Market Size (2017-2028)
  • 8.2 Asia-Pacific Cell Viability Assays Market Size by Type
    • 8.2.1 Asia-Pacific Cell Viability Assays Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Cell Viability Assays Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Cell Viability Assays Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Cell Viability Assays Market Size by Application
    • 8.3.1 Asia-Pacific Cell Viability Assays Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Cell Viability Assays Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Cell Viability Assays Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Cell Viability Assays Market Size by Region
    • 8.4.1 Asia-Pacific Cell Viability Assays Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Cell Viability Assays Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Cell Viability Assays Market Size (2017-2028)
  • 9.2 Latin America Cell Viability Assays Market Size by Type
    • 9.2.1 Latin America Cell Viability Assays Market Size by Type (2017-2022)
    • 9.2.2 Latin America Cell Viability Assays Market Size by Type (2023-2028)
    • 9.2.3 Latin America Cell Viability Assays Market Share by Type (2017-2028)
  • 9.3 Latin America Cell Viability Assays Market Size by Application
    • 9.3.1 Latin America Cell Viability Assays Market Size by Application (2017-2022)
    • 9.3.2 Latin America Cell Viability Assays Market Size by Application (2023-2028)
    • 9.3.3 Latin America Cell Viability Assays Market Share by Application (2017-2028)
  • 9.4 Latin America Cell Viability Assays Market Size by Country
    • 9.4.1 Latin America Cell Viability Assays Market Size by Country (2017-2022)
    • 9.4.2 Latin America Cell Viability Assays Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell Viability Assays Market Size (2017-2028)
  • 10.2 Middle East & Africa Cell Viability Assays Market Size by Type
    • 10.2.1 Middle East & Africa Cell Viability Assays Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Cell Viability Assays Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Cell Viability Assays Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Cell Viability Assays Market Size by Application
    • 10.3.1 Middle East & Africa Cell Viability Assays Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Cell Viability Assays Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Cell Viability Assays Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Cell Viability Assays Market Size by Country
    • 10.4.1 Middle East & Africa Cell Viability Assays Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Cell Viability Assays Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022)
    • 11.1.5 Thermo Fisher Scientific Recent Developments
  • 11.2 Merck
    • 11.2.1 Merck Company Details
    • 11.2.2 Merck Business Overview
    • 11.2.3 Merck Cell Viability Assays Introduction
    • 11.2.4 Merck Revenue in Cell Viability Assays Business (2017-2022)
    • 11.2.5 Merck Recent Developments
  • 11.3 Bio-Rad
    • 11.3.1 Bio-Rad Company Details
    • 11.3.2 Bio-Rad Business Overview
    • 11.3.3 Bio-Rad Cell Viability Assays Introduction
    • 11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2017-2022)
    • 11.3.5 Bio-Rad Recent Developments
  • 11.4 GE
    • 11.4.1 GE Company Details
    • 11.4.2 GE Business Overview
    • 11.4.3 GE Cell Viability Assays Introduction
    • 11.4.4 GE Revenue in Cell Viability Assays Business (2017-2022)
    • 11.4.5 GE Recent Developments
  • 11.5 Danaher
    • 11.5.1 Danaher Company Details
    • 11.5.2 Danaher Business Overview
    • 11.5.3 Danaher Cell Viability Assays Introduction
    • 11.5.4 Danaher Revenue in Cell Viability Assays Business (2017-2022)
    • 11.5.5 Danaher Recent Developments
  • 11.6 BD
    • 11.6.1 BD Company Details
    • 11.6.2 BD Business Overview
    • 11.6.3 BD Cell Viability Assays Introduction
    • 11.6.4 BD Revenue in Cell Viability Assays Business (2017-2022)
    • 11.6.5 BD Recent Developments
  • 11.7 PerkinElmer
    • 11.7.1 PerkinElmer Company Details
    • 11.7.2 PerkinElmer Business Overview
    • 11.7.3 PerkinElmer Cell Viability Assays Introduction
    • 11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2017-2022)
    • 11.7.5 PerkinElmer Recent Developments
  • 11.8 Promega
    • 11.8.1 Promega Company Details
    • 11.8.2 Promega Business Overview
    • 11.8.3 Promega Cell Viability Assays Introduction
    • 11.8.4 Promega Revenue in Cell Viability Assays Business (2017-2022)
    • 11.8.5 Promega Recent Developments
  • 11.9 Biotium
    • 11.9.1 Biotium Company Details
    • 11.9.2 Biotium Business Overview
    • 11.9.3 Biotium Cell Viability Assays Introduction
    • 11.9.4 Biotium Revenue in Cell Viability Assays Business (2017-2022)
    • 11.9.5 Biotium Recent Developments
  • 11.10 Abcam
    • 11.10.1 Abcam Company Details
    • 11.10.2 Abcam Business Overview
    • 11.10.3 Abcam Cell Viability Assays Introduction
    • 11.10.4 Abcam Revenue in Cell Viability Assays Business (2017-2022)
    • 11.10.5 Abcam Recent Developments
  • 11.11 Creative Bioarray
    • 11.11.1 Creative Bioarray Company Details
    • 11.11.2 Creative Bioarray Business Overview
    • 11.11.3 Creative Bioarray Cell Viability Assays Introduction
    • 11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022)
    • 11.11.5 Creative Bioarray Recent Developments
  • 11.12 Biotek Instruments
    • 11.12.1 Biotek Instruments Company Details
    • 11.12.2 Biotek Instruments Business Overview
    • 11.12.3 Biotek Instruments Cell Viability Assays Introduction
    • 11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022)
    • 11.12.5 Biotek Instruments Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer